3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Lung Neoplasms
3
Breast Neoplasms
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Gastrointestinal Neoplasms
2
Uterine Cervical Neoplasms
1
Support of the Family as a Caregiving System
1
Stomach Neoplasms
1
Quality of Life
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pain
1
Otorhinolaryngologic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Mixed Dementias
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Maxillary Sinus Neoplasms
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Follicular
1
Lymphoma
1
Localized Head and Neck Carcinoma
1
Lewy Body Disease
1
Interventions
Oxaliplatin
11
Mitomycin
10
Leucovorin
7
Irinotecan
6
Fluorouracil
6
Hyperthermic Intraperitoneal Chemotherapy
5
Capecitabine
4
Surveys and Questionnaires
3
Cytoreduction Surgical Procedures
3
Cisplatin
3
dehydroftorafur
2
Trastuzumab
2
Thalidomide
2
Mitozytrex
2
Melphalan
2
Interleukin-12 Subunit p35
2
Floxuridine
2
Doxorubicin
2
Cetuximab
2
Biopsy
2
tipifarnib
1
surufatinib
1
sodium thiosulfate
1
sintilimab
1
nintedanib
1
nilotinib
1
motexafin lutetium
1
irinotecan sucrosofate
1
entinostat
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Appendiceal Neoplasms
×
Referral and Consultation
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled